12:00 AM
Mar 18, 2013
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Genmab completes warrant exercise

Genmab A/S (CSE:GEN), Copenhagen, Denmark
Business: Antibodies, Cancer, Autoimmune
Date completed: 3/13/13
Type: Warrant exercise

Read the full 57 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >